Role of bile acids in the control of pancreatic secretion and CCK release
- PMID: 2124998
- DOI: 10.1111/j.1365-2362.1990.tb01778.x
Role of bile acids in the control of pancreatic secretion and CCK release
Abstract
In most species stimulated pancreatic enzyme secretion and CCK release are increased in the absence and inhibited in the presence of luminal bile acids. Changes in CCK release are almost unequivocal in all investigated species. With respect to enzyme secretion, physiological bile acid concentrations seem to be necessary to exert an inhibitory effect on stimulated enzyme output in humans. Bile acids administered in higher concentrations may enhance basal and stimulated pancreatic secretion. Furthermore, the chemical properties of different bile acids (i.e., hydroxylation, conjugation) seem to contribute to their stimulating effect on enzyme secretion as was observed in several species. The rank order of bile acids inhibiting stimulated enzyme secretion in humans is taurocholate greater than taurodeoxycholate greater than taurochenodeoxycholate. On the other hand, chenodeoxycholic acid exerts the strongest stimulating effect on secretion release, which may account for the stimulating effect of this bile acid on exocrine pancreatic secretion. The strongest candidate for the mediator role in bile-acid-induced changes of exocrine pancreatic secretion is CCK (at least in dogs and rats). The CCK cell may be influenced either directly or indirectly. In conclusion, bile acids modulate pancreatic enzyme secretion and CCK release. CCK is a major candidate for this regulatory role under physiological conditions.
Similar articles
-
Physiological control of cholecystokinin release and pancreatic enzyme secretion by intraduodenal bile acids.Gut. 1996 Nov;39(5):661-7. doi: 10.1136/gut.39.5.661. Gut. 1996. PMID: 9026479 Free PMC article. Clinical Trial.
-
The influence of bile acids on the regulation of exocrine pancreatic secretion and on the plasma concentrations of neurotensin and CCK in dogs.Int J Pancreatol. 1993 Feb;13(1):23-30. doi: 10.1007/BF02795196. Int J Pancreatol. 1993. PMID: 8454915
-
Dissociation of cholecystokinin and pancreaticobiliary response to intraduodenal bile acids and cholestyramine in humans.Dig Dis Sci. 1991 Nov;36(11):1625-32. doi: 10.1007/BF01296408. Dig Dis Sci. 1991. PMID: 1935502
-
Feedback inhibition of cholecystokinin secretion by bile acids and pancreatic proteases.Ann N Y Acad Sci. 1994 Mar 23;713:167-79. doi: 10.1111/j.1749-6632.1994.tb44064.x. Ann N Y Acad Sci. 1994. PMID: 8185158 Review.
-
Pathophysiological role of cholecystokinin in humans.J Gastroenterol Hepatol. 2000 Mar;15 Suppl:D71-83. doi: 10.1046/j.1440-1746.2000.02178.x. J Gastroenterol Hepatol. 2000. PMID: 10759224 Review.
Cited by
-
Does impaired gallbladder function contribute to the development of Barrett's esophagus and esophageal adenocarcinoma?J Gastrointest Surg. 2011 Jun;15(6):908-14. doi: 10.1007/s11605-011-1520-z. Epub 2011 Apr 12. J Gastrointest Surg. 2011. PMID: 21484485
-
Direct, concentration-dependent inhibition by taurocholate of pancreatic exocrine secretion and CCK release in conscious rats.Dig Dis Sci. 1994 Jul;39(7):1544-9. doi: 10.1007/BF02088062. Dig Dis Sci. 1994. PMID: 8026268
-
Development of the endocrine cells in the rat pancreatic and bile duct system.Histochem J. 1993 Nov;25(11):807-20. Histochem J. 1993. PMID: 7905468
-
Elobixibat for the treatment of constipation.Expert Rev Gastroenterol Hepatol. 2018 Oct;12(10):951-960. doi: 10.1080/17474124.2018.1522248. Epub 2018 Sep 20. Expert Rev Gastroenterol Hepatol. 2018. PMID: 30204504 Free PMC article.
-
Role of endogenous bile on basal and postprandial CCK release in humans.Dig Dis Sci. 1993 Jul;38(7):1284-90. doi: 10.1007/BF01296080. Dig Dis Sci. 1993. PMID: 8391974
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources